This is an old revision of this page, as edited by Jmax- (talk | contribs) at 05:12, 27 February 2007 (rm nonsense). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 05:12, 27 February 2007 by Jmax- (talk | contribs) (rm nonsense)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound| Clinical data | |
|---|---|
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | 100% |
| Elimination half-life | 7.3 ± 4.0 hours |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.157.848  |
| Chemical and physical data | |
| Formula | C17H21NO3 |
| Molar mass | 287.354 g/mol g·mol |
Etodolac is the International Nonproprietary Name (INN) of 1,8-diethyl-1,3,4,9-tetrahydropyrano-indole-1-acetic acid (empirical formula C17H21NO3), also sold under the trade name Lodine. It is a non-steroidal anti-inflammatory drug (NSAID). It is used to treat pain associated with arthritis and other conditions.
External links
 | This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |
- "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 Oct 2023.